Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Earnings Results

Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) posted its quarterly earnings data on Monday. The biotechnology company reported ($0.75) EPS for the quarter, beating analysts’ consensus estimates of ($0.81) by $0.06, Briefing.com reports. During the same quarter in the previous year, the business earned ($0.87) EPS. Rocket Pharmaceuticals Trading Down 5.0 % Shares of Rocket […]

Related Keywords

Stifel Nicolaus ,Gaurav Shah ,Gotham Makker ,Steward Partners Investment Advisory ,Institutional Trading Of Rocket Pharmaceuticals ,Rocket Pharmaceuticals ,Insider Transactions At Rocket Pharmaceuticals ,Cantor Fitzgerald ,Rocket Pharmaceuticals Company Profile ,News Ratings For Rocket Pharmaceuticals Daily ,Advisor Group Holdings Inc ,Rocket Pharmaceuticals Trading Down ,Rocket Pharmaceuticals Inc ,Wells Fargo Company ,Canaccord Genuity Group ,Life Insurance Co ,Earnings History For Rocket Pharmaceuticals ,Securities Exchange Commission ,Get Free Report ,Pharmaceuticals Trading Down ,Genuity Group ,Chardan Capital ,Exchange Commission ,Director Gotham Makker ,Group Holdings ,Partners Investment Advisory ,Rocket Pharmaceuticals Daily ,Nasdaq Rckt ,Rckt ,Medical ,Earnings ,